Listed

BioNexus Gene Lab Corp: Form 10-Q for the period ended Jun 30, 2023

Filed with the SEC on Aug 16, 2023 and accepted by EDGAR at Aug 16, 2023, 15:26 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-04-01 to 2023-06-30$2.6mus-gaap:Revenues
Revenue6 months2023-01-01 to 2023-06-30$4.9mus-gaap:Revenues
Cost of revenue3 months2023-04-01 to 2023-06-30$2.2mus-gaap:CostOfRevenue
Cost of revenue6 months2023-01-01 to 2023-06-30$4.2mus-gaap:CostOfRevenue
Gross profit3 months2023-04-01 to 2023-06-30$339.7kus-gaap:GrossProfit
Gross profit6 months2023-01-01 to 2023-06-30$708.6kus-gaap:GrossProfit
Operating income3 months2023-04-01 to 2023-06-30−$272.2kus-gaap:OperatingIncomeLoss
Operating income6 months2023-01-01 to 2023-06-30−$322.8kus-gaap:OperatingIncomeLoss
Interest expense6 months2023-01-01 to 2023-06-30$5.5kus-gaap:InterestExpense
Net income3 months2023-04-01 to 2023-06-30−$259.3kus-gaap:NetIncomeLoss
Net income6 months2023-01-01 to 2023-06-30−$328.3kus-gaap:NetIncomeLoss
Operating cash flow6 months2023-01-01 to 2023-06-30−$140.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2023-01-01 to 2023-06-30$14.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2023-06-30$297.1kus-gaap:Cash
Current assetsAt period end2023-06-30$5.2mus-gaap:AssetsCurrent
Total assetsAt period end2023-06-30$7.9mus-gaap:Assets
Current liabilitiesAt period end2023-06-30$1.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-06-30$1.9mus-gaap:Liabilities
Shareholders' equityAt period end2023-06-30$6.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-23-006208. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.